pyridoxal has been researched along with Dementia Praecox in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Altered peripheral carbonyl stress markers, high levels of serum pentosidine, which accumulates following carbonyl stress, and low levels of pyridoxal (vitamin B6), which detoxifies reactive carbonyl compounds, have been reported in a cross-sectional study of chronic schizophrenia." | 3.80 | Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia. ( Arai, H; Hanzawa, R; Higa, M; Higashiyama, R; Hotta, Y; Katsuta, N; Maeshima, H; Nakamura, T; Nishimon, S; Ohnuma, T; Sannohe, T; Shibata, N; Takebayashi, Y; Takeda, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Son, S | 1 |
| Arai, M | 3 |
| Toriumi, K | 2 |
| Andica, C | 1 |
| Matsuyoshi, D | 1 |
| Kamagata, K | 1 |
| Aoki, S | 1 |
| Kawashima, T | 1 |
| Kochiyama, T | 1 |
| Okada, T | 1 |
| Fushimi, Y | 1 |
| Nakamoto, Y | 1 |
| Kobayashi, Y | 1 |
| Murai, T | 1 |
| Itokawa, M | 3 |
| Miyata, J | 1 |
| Tomioka, Y | 1 |
| Numata, S | 1 |
| Kinoshita, M | 1 |
| Umehara, H | 1 |
| Watanabe, SY | 1 |
| Nakataki, M | 1 |
| Iwayama, Y | 1 |
| Toyota, T | 2 |
| Ikeda, M | 1 |
| Yamamori, H | 1 |
| Shimodera, S | 1 |
| Tajima, A | 1 |
| Hashimoto, R | 2 |
| Iwata, N | 1 |
| Yoshikawa, T | 2 |
| Ohmori, T | 1 |
| Tani, E | 1 |
| Ohnuma, T | 2 |
| Hirose, H | 1 |
| Nakayama, K | 1 |
| Mao, W | 1 |
| Nakadaira, M | 1 |
| Orimo, N | 1 |
| Yamashita, H | 1 |
| Takebayashi, Y | 2 |
| Miki, Y | 1 |
| Katsuta, N | 2 |
| Nishimon, S | 2 |
| Hasegawa, T | 1 |
| Komiyama, E | 1 |
| Suga, Y | 1 |
| Ikeda, S | 1 |
| Arai, H | 2 |
| Miyashita, M | 2 |
| Yuzawa, H | 1 |
| Niizato, K | 1 |
| Oshima, K | 1 |
| Kushima, I | 1 |
| Fukumoto, M | 1 |
| Koike, S | 1 |
| Ujike, H | 1 |
| Arinami, T | 1 |
| Kasai, K | 1 |
| Takeda, M | 2 |
| Ozaki, N | 1 |
| Okazaki, Y | 1 |
| Amano, N | 1 |
| Miyata, T | 1 |
| Maeshima, H | 1 |
| Higa, M | 1 |
| Nakamura, T | 1 |
| Sannohe, T | 1 |
| Hotta, Y | 1 |
| Hanzawa, R | 1 |
| Higashiyama, R | 1 |
| Shibata, N | 1 |
| Kobori, A | 1 |
| Horiuchi, Y | 1 |
| Miodownik, C | 1 |
| Cohen, H | 1 |
| Kotler, M | 1 |
| Lerner, V | 1 |
2 reviews available for pyridoxal and Dementia Praecox
| Article | Year |
|---|---|
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.
Topics: Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Neoplasm | 2018 |
Carbonyl stress and schizophrenia.
Topics: Arginine; Biomarkers; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Mu | 2014 |
1 trial available for pyridoxal and Dementia Praecox
| Article | Year |
|---|---|
[Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders].
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Mov | 2003 |
4 other studies available for pyridoxal and Dementia Praecox
| Article | Year |
|---|---|
Association between enhanced carbonyl stress and decreased apparent axonal density in schizophrenia by multimodal white matter imaging.
Topics: Axons; Glycation End Products, Advanced; Humans; Pyridoxal; Schizophrenia; White Matter | 2023 |
Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Female; Fluorometry; Glycat | 2019 |
Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Lysine | 2014 |
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Arginine; Biomarkers; Cross-Sectional | 2014 |